We evaluated ETS-1 expression in a panel of melanoma cell lines at different stages of progression, including primary vertical growth phase (VGP) melanomas, as well as subcutaneous and lymph-node metastases (Felicetti et al., 2004). The gene discussed is ETS1; the disease is melanoma.